Pukyong National University, FarmCAD, Busan City, etc., Selected for 'Quantum Computing-Based Quantum Advantage Challenge Research' Project

A consortium consisting of Pukyong National University, PharmCAD, Busan City, and other universities, companies, and local governments has been selected for the Ministry of Science and ICT and the National Research Foundation of Korea's '2023 Quantum Computing-Based Quantum Advantage Challenge Research Project.'

This project aims to create innovative cases utilizing quantum computing with significant industrial ripple effects to establish a quantum ecosystem and secure market leadership. A total of five tasks were selected in this project call.

The consortium including Pukyong National University was selected for the research project titled "Quantum Advantage in Innovative Anticancer Drug Development: Development of Quantum Software Technology for Predicting Atypical Protein Structures," and will invest a total of 3.05 billion KRW, including 2.75 billion KRW in national funds and 300 million KRW in city funds, to carry out the project until 2025.

Professor Woo Sang-wook of the Department of Physics at Pukyong National University serves as the consortium's research director. PharmCAD, an AI-based new drug development company led by Professor Woo, will take the lead, with participation from Pukyong National University, KAIST, Busan City, and the Busan IT Industry Promotion Agency, among other universities, companies, and local governments, to develop innovative technologies utilizing quantum computing.

Pukyong National University.

Quantum computing uses qubits, which have superposition properties, instead of bits, the basic unit of conventional computers, significantly increasing computational processing speed. It is expected to have a major impact on innovations in various fields such as artificial intelligence.

Following this project selection, PharmCAD, a Busan-based company, will be responsible for the verification and commercialization of atypical structure protein data for anticancer drug development, while Pukyong National University, led by Professor Han Young-sun, plans to provide an optimized quantum computer compiler environment to enhance the performance of quantum circuits.

Additionally, KAIST will be responsible for developing quantum computer software and algorithms, as well as elucidating and demonstrating the principles of quantum advantage. Busan City and the Busan IT Industry Promotion Agency will secure city budget funding and continuously discover and promote quantum technology companies, providing support.

Professor Woo Sang-wook, CEO of PharmCAD and professor at Pukyong National University, stated, "Based on a close cooperative system rooted in the region, we will strive to develop quantum software technology optimized for the demands of the industrial field to secure a competitive advantage in the field of quantum computing applications."

This content was produced with the assistance of AI translation services.